Drug
Difluprednate
Difluprednate is a pharmaceutical drug with 6 clinical trials. Historical success rate of 83.3%.
Total Trials
6
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
83.3%
Based on 5 completed trials
Completion Rate
83%(5/6)
Active Trials
0(0%)
Results Posted
40%(2 trials)
Terminated
1(17%)
Phase Distribution
Ph phase_3
5
83%
Ph phase_4
1
17%
Phase Distribution
0
Early Stage
0
Mid Stage
6
Late Stage
Phase Distribution6 total trials
Phase 3Large-scale testing
5(83.3%)
Phase 4Post-market surveillance
1(16.7%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
83.3%
5 of 6 finished
Non-Completion Rate
16.7%
1 ended early
Currently Active
0
trials recruiting
Total Trials
6
all time
Status Distribution
Completed(5)
Terminated(1)
Detailed Status
Completed5
Terminated1
Development Timeline
Analytics
Development Status
Total Trials
6
Active
0
Success Rate
83.3%
Most Advanced
Phase 4
Trials by Phase
Phase 35 (83.3%)
Phase 41 (16.7%)
Trials by Status
completed583%
terminated117%
Recent Activity
0 active trials
Showing 5 of 6
terminatedphase_4
Macular Edema Nepafenac vs. Difluprednate Uveitis Trial
NCT01939691
completedphase_3
Study of Difluprednate in the Treatment of Inflammation Following Ocular Surgery (ST-601-004)
NCT00616993
completedphase_3
Study of Difluprednate in the Treatment of Inflammation Following Ocular Surgery (ST-601-003)
NCT00616070
completedphase_3
Study of Difluprednate in the Treatment of Inflammation Following Ocular Surgery (ST-601A-002b)
NCT00430092
completedphase_3
Study of Difluprednate in the Treatment of Inflammation Following Ocular Surgery (ST-601A-002a)
NCT00429923
Clinical Trials (6)
Showing 6 of 6 trials
NCT01939691Phase 4
Macular Edema Nepafenac vs. Difluprednate Uveitis Trial
NCT00616993Phase 3
Study of Difluprednate in the Treatment of Inflammation Following Ocular Surgery (ST-601-004)
NCT00616070Phase 3
Study of Difluprednate in the Treatment of Inflammation Following Ocular Surgery (ST-601-003)
NCT00430092Phase 3
Study of Difluprednate in the Treatment of Inflammation Following Ocular Surgery (ST-601A-002b)
NCT00429923Phase 3
Study of Difluprednate in the Treatment of Inflammation Following Ocular Surgery (ST-601A-002a)
NCT00501579Phase 3
Study of Difluprednate in the Treatment of Uveitis
All 6 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 6